TXNIP and breast cancer: They have higher acidification and oxygen consumption rates than luminal breast cancer cells, driven by factors like EGF signaling and c-MYC, which suppress thioredoxin-interacting protein (TXNIP), an inhibitor of glycolysis (Sun et al., 2020; Wang Z. et al., 2020).